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INTRODUCTION 
This study was undertaken to determine the distribution and effects 
of bacterial endotoxin. Two, distinctly different approaches have been 
used in this investigation. Initially, Pseudomonas, Bacteroides, and 
Listeria have been tested for endotoxic activity using the vincristine­
treated mouse as one assay system. Another assay used to detect endo­
toxic activity was the ability to evoke resistance to a lethal dose of 
endotoxin after pretreatment with these three genera of bacteria. 
Subsequently the effect of endotoxin and endotoxin-like materials on the 
course of the disease that developed after infection of mice with 
Naegleria fowleri was determined. 
A synergistic interaction has been demonstrated with bacterial 
endotoxin and a variety of antineoplastic agents resulting in lethality 
for mice. Because the enhanced toxicity of combinations of drug and 
endotoxin observed in mice may also occur in man, it is important for 
clinicians to be aware of endotoxic activity of bacteria in managing 
those patients undergoing long hospitalization and lengthy drug usage. 
For the patient with severe burn, a malignant disease or recovering from 
radical surgery the prospect of bacterial infection constitutes a real 
hazard. Many of the antineoplastic agents are immunosuppressive which 
also weakens host defenses and increases the chance of opportunistic 
infection (Rose, 1973). 
Bacteroides, Pseudomonas, and Listeria were chosen to be assayed for 
endotoxic activity because the organisms are easily isolated from man 
or the environment and are not usually pathogenic except in the compro­
mised host. The presence of endotoxin in Pseudomonas is well documented 
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(Hancock et al., 1970, Sadoff, 1974, and Chester et al ., 1972) but lit­
erature concerning characterization of endotoxin in Bacteroides and 
Listeria is sparse. 
According to Sonnenwirth et al. (1972) bacteremia due to Bacteroides 
is not uncommon and its frequency has increased more than 10 fold over 
the last decade. The role of endotoxin in anaerobic gram-negative bacter­
emia remains to be clarified especially as only a few Bacteroides species 
naye been examined in regard to endotoxin content. It is not known 
whether the lipopolysaccharide (LPS) of all gram-negative, anaerobic, 
nonspore-forming rods contain ketodeoxyoctonate. Detection of endotoxin 
in plasma in patients with sepsis caused by gram-negative anaerobes by 
the L imul us assay has not been reported (Sonnenwi rth et a 1., 1972). 
Sonnenwirth et al. (1972) showed with a modified Limulus assay that 
the LPS extracted from�· fragilis and�· melaninogenicus yielded positive 
assays in vitro at concentrations of lo-2 to lo-6 mg/ml. Ketodeoxyoctonate 
(KDO) determinations demonstrated that�· fragilis and�· melaninogenicus 
LPS contained 0.03558 � moles KDO/mg and 0.0332 � moles KDO/ mg respectively 
(�onnenwirth et al., 1972); these values are about 10 fold less than those 
for Salmonella typhimurium (Osborn et al ., 1972). 
Listeria monocytogenes differs from the two organisms discussed pre­
viously in that it is a gram-positive bacterium. Extracts from the cell 
wall of�· monocytogenes have been reported to be mitogenic (Cohen et al ., 
1975, Mara et al., 1974). Stanley (1949) isolated a factor from L. 
monocytogenes called monocyte producing agent (MPA) that causes a mono­
cytosis in white mice and is associated with short term lymphopenia. 
An endotoxin-like substance isolated from�· monocytogenes, factor Ei 
produces a monocytosis also. This monocytosis is associated with a 
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leukocytosis. The monocytosis produced by factor Ei is potentiated by 
the lipid moiety of Ei (Patocka et al ., 1974). 
According to Cohen et al. (1975), a crude cell wall rich fraction of 
L. monocytogenes contains a substance or substances that are mitogenic for 
B cells in mice (Cohen, 1975). Patocka et al. (1974) found factor Ei 
isolated from�· monocytogenes when used for both sensitizing and reacting 
factors failed to give a Shwartzman reaction. However, when factor Ei 
was used for sensitization followed by f. coli LPS as the reacting factor 
a marked Shwartzman reaction occurred. Also, Ei factor (4.5 mg/kg) 
given iv to rabbits was pyrogenic. Factor Ei is antigenic and in conven­
tional and inbred mice no lethal effect was observed. However, mice ad­
ministered a sublethal dose of actinomycin D and factor Ei died within 7 
days. Patocka et al. (1974) also observed that the toxic effect of actino­
mycin D in Ei treated mouse can be prevented by anti-Ei hyperimmune serum 
(Patocka et al., 1974). 
Srivastava and Siddique (1975) found that classic gram-negative 
bacterial endotoxin-like biologic material from�· monocytogenes produced 
toxicosis in rabbits, mice, and dogs with signs and pathologic character­
istics of endotoxic shock. The toxic component was found to have the 
following endotoxin-like properties; pyrogenicity in rabbits, edema and 
erythema in rabbit skin, lethality in chicken embryos and active immunity 
in mice (Srivastava and Siddique, 1975). 
According to Rose (1973) and Bradley et al. (1975) vincristine and 
mithramycin produced marked potentiation of endotoxin lethality in mice 
(Rose, 1973, Bradley et al., 1975). For this reason the mithramycin­
treated mouse and the vincristine-treated mouse were used to assay for 
endotoxic activity. 
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Mithramycin is a potent inhibitor of ribonucleic acid (RNA) syn­
thesis. According to Dawson (1972) this compound binds to deoxyribo­
nucleic acid (DNA) and so inhibits DNA-dependent RNA synthesis (Dawson, 
1972). 
When sublethal doses of endotoxin and mithramycin were administered 
simultaneously a marked increase in lethality in mice was observed. The 
mean lethal dose on day 4 was 1.7 mg/kg. The mean lethal dose on day 4 
for endotoxin was 11.2 mg/kg. Mithramycin in combination with 2 mg/kg 
endotoxin resulted in a 19 fold reduction in the mean lethal dose for the 
drug on day 4. On the other hand, endotoxin with 0.25 mg/kg mithramycin 
resulted in a 100 fold reduction in the mean lethal dose of endotoxin on 
day 5. The slopes of the dose response curve of the combination were 
parallel to the slopes of the dose response curves of mithramycin alone 
and endotoxin alone indicating that the lethal action of the combination 
did not involve a new toxic mechanism. The isobologram based upon 50% 
lethal doses of combinations of mithramycin and endotoxin was markedly 
synergistic. Mice usually died within 24 to 48 hours after administra­
tion of the combination of mithramycin and endotoxin. Mice pretreated 
with endotoxin were significantly protected from lethal action of the 
combination. Therefore the mechanism of the synergy appears to be drug 
induced hyperreactivity to endotoxicity (Bradley et al ., 1975). According 
to Bradley et al. (1975) the mithramycin treated mouse is a sensitive 
indicator for endotoxic acitvity in complex materials. Specificity of the 
lethal effect can be assessed by rendering the mice resistant to endotoxin 
by pretreatment (Bradley et al., 1975). 
Vincristine (VNC) is an alkaloid from the plant Vinca rosea and it 
inhibits mitosis. This antineoplastic agent when given in combination 
with endotoxin exhibits a marked increase in lethality for mice. One or 
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4 mg/kg VNC resulted in a significant 13.1 and 1076 fold enhancement 
in lethality respectively (Rose et al ., 1972). 
According to Rose (1973), i· typhosa endotoxin potentiated VNC 
toxicity in mice. The LD50 value with respect to VNC 3 days following 
administration was reduced from 8.0 mg/kg when administered alone to 1.2 
mg/kg, 0.95 mg/kg and 0.54 mg/kg when given in combination with 1 mg/kg, 
2 mg/kg, and 4 mg/kg i· typhosa endotoxin respectively. Potentiation ratios 
were 6.7, 8.4, and 14.8 for VNC respectively with doses of endotoxin 
of 1 mg/kg, 2 mg/kg and 4 mg/kg. The slopes of these dose response curves 
were parallel to the slope of the dose response curve for VNC alone. This 
was one of the most potent enhancements of drug lethality described by 
Rose ( 1973) . 
Since the slopes of the dose response curves for the combination of 
VNC and LPS are parallel to the slopes of the dose response curve for each 
agent alone, one cannot attribute lethality to drug toxicity to exclusion of 
the endotoxin toxicity. Mice pretreated with multiple doses of i· typhosa 
LPS successfully reduced the enhanced lethality with VNC-LPS challenge. 
However, mice pretreated with LPS and challenged with 5 mg VNC/kg only had 
a significantly higher mortality than untreated mice receiving the same 
challenge dose of VNC. From the above results it appears that the role 
of VNC involves an enhanced reaction of the host to endotoxin. It is the 
availability of endotoxin for potentiating VNC lethality that is substan­
tially reduced in an endotoxin pretreated animal because of more rapid 
clearance or detoxification of the toxin (Rose, 1973). 
R0se".·1 (1973) observed that administration of VNC to rhesus monkeys 
predisposed the animals tot· aeruginosa sepsis and death. Eleven out 
of 14 monkeys pretreated 4 days earlier with 2.5 mg VNC and given intra­
venous inoculation of 5 X 1010 Pseudomonas organisms died. None of the 
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monkeys given Pseudomonas alone died. Saslaw suggested that VNC induced 
leukopenia was causally related to Pseudomonas sepsis and death in monkeys. 
According to Rose (1973), Pseudomonas endotoxin may have interacted with 
VNC to augment the observed lethality (Rose, 1973). 
Endotoxin has many other effects on the host other than those 
mentioned previously. Another interesting effect of endotoxin is its 
ability to enhance or inhibit the pathogenicity of infection depending 
on the infecting microorganism, dose and route of injection of endotoxin, 
and the interval between administration of toxin and initiation of infec­
tion (Cluff, 1971). 
Primary amebic meningoencephalitis was chosen as the experimental 
model to see if endotoxin and endotoxin-like materials could alter the 
course of infection. The etiological agent of primary amebic meningo­
encephalitis is Naegleria fowleri (Duma et al., 1969). Outbreaks of 
primary amebic meningoencephalitis have been reported in Australia, 
Czechoslovakia, and the United States. According to Duma et al. (1969) 
clinicopathologically the disease presents a unique picture. Those 
affected have been almost always healthy children or young adults with a 
history of swimming in fresh or brackish water during the week before 
onset of symptoms. Spinal fluids have been typical of acute purulent 
meningitis. The course has been one of rapid deterioration and despite 
intensive therapy, death has occurred in three to five days (Duma et al . , 
1969). 
The mouse as an experimental model for studying primary amebic 
meningoencephalitis is uniquely appropriate since the existence of this 
disease in man was suggested following the discovery of fatal meningo­
encephalitis in mice after intranasal inoculation of a species of 
Acanthamoeba. When primary amebic meningoencephalitis was subsequently 
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reported in humans the remarkable similarity of the disease occurring in 
man to that produced experimentally was promptly recognized ( Culbertson 
et al., 1958). 
The basic features of the disease in man have been noted in experi­
mental infections in the mouse namely the same incubation period and portal 
of entry, residence of amebae in the olfactory mucosa with invasion and 
migration through submucosal structures and into nerve plexuses, passage 
of amebae through pores of the cribriform plate and into the subarachnoid 
space, subsequent invasion of olfactory bulbs and lobes with spread to 
more distant areas of the brain ( Martinez et al ., 1973). 
Treatment of naeglerial infections has been disappointing. Initially 
treatment consisted of antibacterial agents and antiprotozoal drugs with 
no success. These drugs are probably ineffective because they fail to 
cross the blood brain barrier. Amphotericin B has been the only drug that 
showed promising effects on naeglerial infection ( Carter, 1972). The 
literature states that a 14 year old male from Australia was cured of 
primary amebic meningoencephalitis after intense treatment with the anti­
fungal drug ( Shumaker et al ., 1971). 
Endotoxic activity of several strains of bacteria were assayed in this 
study using the vincristine treated mouse and increased resistance of mice 
to a lethal dose of endotoxin because of pretreatment. Also the ability 
of endotoxin and endotoxin-like materials to protect mice from a fatal 
outcome of primary amebic meningoencephalitis was determined. 
All of the strains of Pseudomonas proved to have endotoxic activity 
by the two assay systems used. Some of the strains of Bacteroides and 
Listeria had endotoxic activity by the above assays. It was also found 
that the course of the naeglerial infection could be altered initially 
by the pretreatment of mice with endotoxin. Endotoxin-like materials, 
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however, afforded no increased resistance of mice to primary amebic 
meningoencephalitis. 
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Materials and Methods 
Male BALB/c and male DUB/ICR mice weighing 20-25 g were used in 
all experiments. Mice were obtained from Flow Research Animals, Inc. 
Dublin, Virginia. They were allowed to adjust to their new environment 
for at least 1 week prior to experimentation. The mice were given 
free access to food (Purina Lab Chow, Purina Ralston Corp., St. Louis, 
Mo.) and water. 
All drug solutions were prepared so that 0.01 ml/g of mouse weight 
would provide the desired dose. All drugs and LPS injections were 
given simultaneously by the intraperitoneal route unless otherwise 
specified. 
The folowing drugs were dissolved in 0.15 M NaCl: vincristine 
sulfate (NSC-67574; Eli Lilly and Company, Indianapolis, Ind.), and 
mithramycin (NSC-24559; Charles Pfizer and Company, Clifton, N. J.). 
Escherichia coli 0127:B8 LPS, f. coli 026:B6 LPS, f. coli 0111 :B4 
LPS (all Boivin preparations of LPS, Difco Laboratories, Detroit, Mich.) 
and f. coli 026:B6 LPS, and Salmonella typhosa 0901 LPS (Westphal 
preparations of LPS, Difco) were suspended in 0.15 M NaCl. E. co 1 i 
026:B6 LPS (Boivin preparation, Difco) was used unless otherwise 
specified. 
Bacteroides strains were kindly supplied by P. B. Hylemon 
(Department of Microbiology, Virginia Commonwealth University). The 
Bacteroides cultures were grown overnight at 37° C under anaerobic 
conditions in medium containing 1 g peptone, 1 g yeast extract, 0.5 g 
glucose, 4 ml salt solution, and 100 �g hemin per 100 ml distilled H20. 
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The salts solution contained 0.02 g cac12, 0.02 g MgS04, 0.1 g K2HP04, 
0.1 g KH2P04, 1 g NaCl per 100 ml distilled H2o. After autoclaving 0.1 g 
L-cysteine and 0.4 g Na2co3 per 100 ml of medium were added and the pH 
adjusted to 7.0 with sterile 6 N HCl. 
The Listeria strains were kindly supplied by H. J. Welshimer 
(Department of Microbiology, Virginia Commonwealth University). The 
Listeria cultures were grown overnight at 370 C in a medium consisting 
of 20 g of tryptose (Difco), 2 g of NaCl, 3.5 g Na2HP04 and 2 g glucose 
per liter. 
The Pseudomonas strains were kindly supplied by P. V. Phibbs 
(Department of Microbiology, Virginia Commonwealth University). The 
Pseudomonas cultures were grown overnight in a controlled environment 
incubator shaker (New Brunswick Scientific, New Brunswick, N. J.) at 
37° C in nutrient broth consisting of 1 g peptone (Difco), 0.3 g beef 
extract (Difco) and 0.5 g NaCl per 100 ml distilled H20. 
All bacterial cells were harvested by centrifugation in a refrig­
erated centrifuge at 9000 X G for 15 min and suspended in sterile 0.15 M 
NaCl. The turbidity at 420 nm was measured on a spectrophotometer 
(Spectronic 20, Bausch and Lomb, Rochester, N. Y.). Listeria cells 
were killed prior to harvesting by heating in a 70° C water bath for 
1 hr. Pseudomonas cells were harvested, collected in saline and killed 
by heating in a 700 C water bath for lhr. 
The protozoan culture Naegleria fowleri (Lee strain) was kindly 
supplied by D. T. John (Department of Microbiology, Virginia Common­
wealth University). Naegleria was grown in Nelson's medium consisting 
of Page saline (0.012 g NaCl, 400 �g Mgso4·7H2o, 400 �g CaC12·2H20, 0.0142 g 
Na2HP04, 0.0136 g KH2Po4 per 100 ml distilled H20) supplemented with 
0.1 g liver infusion (Oxoid, London, England), 0.1 g glucose, and 2 ml 
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calf serum (Grand Island Biologicals Company, Grand Island, N. Y.) per 
100 ml of Page saline. Medium (25 ml) in tissue culture flasks 75 cm2 
(Falcon Plastics, Oxnard, Cal.) were inoculated and incubated 96 hr at 
37° c. 
The trophozoites were harvested by centrifugation at 4000 X G for 
10 min in a refrigerated centrifuge, washed with Page saline (described 
above), washed with 0.15 M NaCl, suspended in 0.15 M NaCl and counted 
using a hemocytometer. The cells were then diluted so that 0.2 ml 
would deliver the desired inoculum. All N. fowleri was given intra­
venously unless otherwise specified. 
Mice surviving from naeglerial infection were divided into two 
groups. Half of the mice were rechallenged intravenously with�· 
fowleri (5.0 X 106 trophozoites/mouse). After 14 days both groups of 
survivors were treated with 200 mg cyclophosphamide (Mead Johnson Lab­
oratories, Evansville, Indiana)/kg administered intraperitoneally. 
Mice were also administered N. fowleri intraperitoneally and sub­
cutaneously. After 17-20 days, the mice challenged ip were rechall­
enged iv with 5.0 X 106 Naegleria/mouse. 
Lipid A was extracted from£. coli 0127:88 lipopolysaccharide 
by a procedure adapted from the method of Galanos et al. (1969). The 
absence of 2 keto-3-deoxyoctonate as confirmed by the thiobarbiturate 
assay of Waravdekar and Saslaw (1959) was used to establish that hy­
drolysis was complete. Complexes of lipid A and bovine serum albumin 
(Sigma Chemical Co., St. Louis, Mo.) or concanavalin A (grade IV; 
Sigma) were prepared by methods described by Galanos et al. (1972). 
Immediately before use the complexes were suspended in distilled water 
and dispersed with sonication. Complexes of bovine serum albumin (Sigma) 
with myristic acid (Sigma) or N,N-dimethyl myristamide (Sigma) and com-
12 
plexes of concanavalin A (Sigma) with beta hydroxymyristic acid were 
also tested for endotoxic activity. Immediately before use the com­
plexes were suspended in distilled water and dispersed with sonication. 
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RESULTS 
Enhanced lethality of combinations of mithramycin and LPS occurred 
when the two agents were administered simultaneously. LPS given intra­
peritoneally (ip) or intravenously (iv) rendered the mice hyperreactive 
to mithramycin administered ip or iv (Table 1). The ip route of admin­
istration was chosen for subsequent work because more mice were killed 
for a given dose by the ip route than by the iv route and because of 
the ease of inoculation by the ip route. 
Five LPS preparations were tested for their ability to interact 
in vivo with mithramycin. Four of the preparations were from f. coli; 
two of these were prepared by the Boivin technique. The other three 
LPS preparations were obtained by the Westphal technique (Table 2). 
All five preparations given in combination with 0.5 mg mithramycin/kg 
resulted in enhanced lethality. LPS from E. coli 026:B6 was not as 
potent as LPS from f. coli Ol27:B8, f. coli 0111 :B4 or i· typhosa 
0901. E. coli Ol26:B6 LPS (B) (Table 2) was selected for subsequent 
experiments because of its intermediate potency and because f. coli 
is found as part of the normal flora in man and mouse. 
Three genera of bacteria have been tested for endotoxic activity 
using the vincristine-treated mouse as one assay system. Another assay 
used to detect endotoxic activity was the ability to evoke resistance to 
a lethal dose of endotoxin after pretreatment with three genera of 
bacteria. 
Table 3 shows that high doses of all Pseudomonas aeruginosa strains 
tested caused death in both the untreated and the vincristine-treated 
mouse within 24 hr. When the sample of bacteria was diluted approxi-
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mately l :4 (see Table 4) there was substantial death in all the vincris­
tine treated animals. Only two of the strains of Pseudomonas (PPR 37 
and PPR 38) when administered alone caused death in mice. Table 5 
shows that all strains oft· aeruginosa afforded protection to mice 
challenged with a lethal dose of bacterial endotoxin. By the two assay 
systems used all strains oft· aeruginosa possess endotoxic activity. 
Seven strains of Bacteroides were tested for endotoxic activity. 
All strains of Bacteroides were members of the species B. fragilis 
except 7989 which was a strain of�· melaninogenicus. 
Four of the seven strains of Bacteroides (7989, 5482, 4245, and 
2393) showed endotoxic activity in the vincristine treated mouse 
(Table 6). All strains of Bacteroides protected mice from subsequent 
challenge with a lethal dose of LPS (Table 7). 
Mice treated with the following strains of Listeria monocytogenes 
(19303, PW, 0-9, V-6, and H-3) were rendered somewhat more susceptible 
to a dose of l mg VNC/kg (Table 8). Mice challenged with five strains 
of Listeria monocytogenes (MCV, V-5, T4b, FH-1, and T3b) were not detect­
ably sensitized to heat killed cells by l mg VNC/kg. Mice given a single 
dose of heat killed Listeria cells 4-7 days prior to challenge with 
20 mg [. coli LPS/kg were protected when pretreated with 19303, PW, D-9, 
T3b and H-3 but not when pretreated with MCV, V-5, T4b, FH-1 and V-6 
(Table 9). 
The time of death after simultaneous administration of a bacterial 
suspension and l mg VNC/kg is shown in Figure l. Mice administered 
20 mg LPS/kg alone all died within the first 24 to 48 hr. Time of 
death in mice given bacterial suspensions and VNC was delayed compared 
to the time of death after the LPS alone. 
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TABLE 1 
Effect of route of administration on the 
enhanced lethality of mithramycin and LPSa 
Mithramycin Route for No. of % Dead 
Dose mg/kg Route O.lmg LPS/kg mice by day 4 
0.5 ip 20 0 
0.5 iv 30 0 
0.5 iv 20 0 
0.5 ip 10 0 
0.5 ip ip 30 97 
0.5 ip iv 30 70 
0.5 iv ip 30 53 
0.5 iv iv 30 77 
0.25 iv 8 0 
0.25 iv ip 30 10 
0.25 ip iv 40 10 
0.25 iv iv 30 23 
0.25 ip ip 30 41 
aMale DUB/ICR mice were injected with mithramycin and �· typhosa 0901 
(Westphal) LPS simultaneously by the routes and doses indicated. 
Mithramycin 
0.5mg/kg 
0.5mg/kg 
0.25mg/kg 
0.25mg/kg 
0.5mg/kg 
0.5mg/kg 
0.5mg/kg 
0.5mg/kg 
0.25mg/kg 
0.25mg/kg 
0.25mg/kg 
0.25mg/kg 
0.5mg/kg 
0. 5mg/kg 
0.25mg/kg 
0.25mg/kg 
0.5mg/kg 
0.5mg/kg 
0.25mg/kg 
0.25mg/kg 
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TABLE 2 
Specificity of the in vivo lethal interaction 
between mithramycin and bacterial LPSa 
LPS 
E. coli 0127:B8 (B) 
f. coli 0127:B8 (B) 
E. 
E. 
E. 
E. 
-
coli 0127:B8 
coli 0127:B8 
coli 026:B6 
coli 026:B6 
f. co 1 i 026: B6 
f. co 1 i 026: B6 
E. coli 026:B6 
---
E. coli 026:B6 
---
E. coli 026:B6 
E. coli 026:B6 
E. coli 0111 :B4 
E. coli 0111 :B4 
E. coli 0111 :B4 
E. coli 0111 :B4 
s. t.z-:ehosa 0901 
s. t.z-:ehosa 0901 
s. t.z-:ehosa 0901 
s. t.z-:ehosa 0901 
(B) 
(B) 
(B) 
(W) 
(B) 
(W) 
(B) 
(\�) 
(B) 
(W) 
(W) 
(W) 
(W) 
(W) 
( �J) 
(W) 
(W) 
(W) 
No. of Mice 
lmg/kg 10 
O.lmg/kg 10 
1 .Omg/kg 10 
O.lmg/kg 10 
1 .Omg/kg 10 
lmg/kg 10 
O.lmg/kg 10 
O.lmg/kg 10 
1 .Omg/kg 10 
1 .Omg/kg 10 
O.lmg/kg 10 
O.lmg/kg 10 
lmg/kg 10 
O.lmg/kg 10 
1 .Omg/kg 10 
O.lmg/kg 10 
lmg/kg 10 
0. lmg/kg 10 
1 .Omg/kg 10 
0 .lmg/kg 10 
% Dead 
100 
100 
60 
50 
90 
80 
60 
70 
40 
0 
0 
0 
80 
100 
90 
100 
100 
100 
100 
100 
aMale BALB/c mice were injected simultaneously by the ip route with 
mithramycin and LPS. (B) and (W) refer to Boivin and Westphal prepara-
tions respectively. A dose of lmg f. coli 026:B6 (B)/kg killed 1 of 10 
treated mice; this dose of the other five LPS preparations did not kill 
any of the treated mice (10 mice/group). 
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TABLE 3 
Capability of heat-killed strains of Pseudomonas 
to enhance the lethal action of vincristine for micea 
Strainb A420 lmg VNC/kg No. mice % Dead 
PPR 25 45 10 80 
PPR 25 45 + 10 80 
PPR 37 46 10 90 
PPR 37 46 + 10 100 
PPR 38 40 10 80 
PPR 38 40 + 10 100 
PPR 17 45 10 60 
PPR 1 7  45 + 10 90 
PPR 43 39 10 90 
PPR 43 39 + 10 100 
PPR 42 44 10 70 
PPR 42 44 + 10 100 
PPR 35 25 9 89 
PPR 35 25 + 10 90 
PPR 11 41 10 100 
PPR 11 41 + 10 90 
PPR 18 45 10 60 
PPR 18 45 + 10 80 
PPR 36 46 10 80 
PPR 36 46 + 10 80 
1 mg LPS/ kg 10 0 
lmg LPS/kg + 10 20 
+ 30 10 
aoUB/ICR male mice were injected simultaneously ip with Pseudomonas 
(0.01 ml/g mouse; the turbidity of the suspension is indicated in 
the table) and lmg VNC/kg where indicated. The percent of animals 
dead within 7 days is recorded. 
bAll strains of Pseudomonas were isolated from patients with cystic 
fibrosis. 
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TABLE 4 
Capability of heat-killed st�ains of Pseudomonas aeruginosa 
to enhance the lethal act1on of vincristine for miced 
Strain lmg VNC/kg No. mice % Dead 
PPR 25 
PPR 25 
PPR 37 
PPR 37 
PPR 38 
PPR 38 
PPR 17 
PPR 17 
PPR 43 
PPR 43 
PPR 42 
PPR 42 
PPR 35 
PPR 35 
PPR 11 
PPR 11 
PPR 18 
PPR 18 
PPR 36 
PPR 36 
1 mg LPS/kg 
lmg LPS/kg 
9 
9 
11 
11 
9 
9 
10 
10 
8 
8 
8 
8 
8 
8 
10 
10 
11 
11 
11 
11 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
30 
0 
60b 
20 
60 
10 
40 
0 
40 
0 
40 
0 
40 
0 
40 
0 
30 
0 
30 
0 
20 
0 
20 
10 
aDUB/ICR male mice were injected simultaneously ip with Pseudomonas 
(0.01 ml/g mouse; the turbidity of the suspension is indicated in 
the table) and lmg VNC/kg where indicated. The percent of animals 
dead within 7 days is recorded. 
bsignificant at p<0.02 for the VNC-treated mice in contrast to the 
untreated control. 
Combining the results for all strains of�· aeruginosa, the VNC­
treated mice are significantly more sensitive to LPS than the 
untreated mice at p<O.Ol. 
19 
TABLE 5 
. 
Capabi�ity of strains of Pseudomonas to produce 
1ncreased res1stance to lethal doses of bacterial endotoxina 
Strain A420 No. mice % Dead 
PPR 25 9 10 10 
PPR 37 11 8 0 
PPR 38 9 9 11 
PPR 17 10 10 0 
PPR 43 8 10 0 
PPR 42 8 10 0 
PPR 35 8 10 10 
PPR 11 10 10 10 
PPR 13 11 10 0 
PPR 36 11 10 0 
20mg LPS/kg 10 60 
aoUB/ICR male mice were given a single injection ip with Pseudomonas 
(0.01 ml/g of mouse; the turbidity of the suspension is indicated 
in the table). About 1 week later mice were challenged with 20mg 
E. coli 026:B6 LPS (B). p<O.Ol for all pretreated groups compared 
-
--
to the untreated group. 
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TABLE 6 
Capability of strains of Bacteroides 
to enhance the lethal action of vincristine for micea 
Strain A420 lmg VNC/kg No. mice 
% 
Dead 
7989b 43 20 0 
7989b 43 + 20 40d 
5482c 26 10 0 
5482c 26" 
+ 10 40 
4245c 19 10 10 
4245c 19 + 10 40 
2393c 39:: 20 0 
2393c 39 + 20 25d 
3524c 36 10 0 
3524c 36 + 10 0 
3452-Ac 41 10 0 
3452-Ac 41 + 10 0 
25285c 38 10 0 
25285c 38 + 10 0 
lmg LPS/kg 10 0 
lmg LPS/kg + 10 20 
aDUB/ICR male mice were injected simultaneously ip with Bacteroides 
(0.01 ml per lg of mouse; the turbidity of the suspension is indi­
cated in the table) and lmg VNC/kg when indicated. The percent of 
animals dead within 7 days is recorded. 
bB. melaninogenicus 
cB. fragilis - Subspecies of�· fragilis are: fragilis, 25285 and 
2393; vulgatus, 4245; thetaiotaomicron, 5482; ovatus, 3524; dista-
sonis, 3452-A. 
dsignificant at p<0.02 for the VNC-treated mice in contrast to the 
untreated control. 
Combining the results for all strains of�· fragilis, the VNC­
treated mice are si�oificantll moreasen�itive to LPS than the 
untreated mice at0p<O.Ol. 
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TABLE 7 
Capability of strains of Bacteroides to produce 
increased resistance to lethal doses of bacterial endotoxina 
Strain A420 No. mice % Dead 
7989 42 20 20 
5482 26 10 10 
4245 19 10 30 
2393 39 20 5 
3524 36 10 10 
3452A 41 10 0 
25285 38 10 10 
20mg/kg LPS 10 60 
aDUB/ICR male mice were given a single injection ip with Bacteroides 
(0.01 ml/g of mouse; the turbidity of the suspension is indicated 
in the table). About 1 week later mice were challenged with 20mg 
f. coli 026:B6 LPS (B). The specific identification of these strains 
is given in Table 6. p<0.05 for all pretreated groups compared to 
the untreated group. 
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TABLE 8 
Capability of heat-killed strains of Listeria 
to enhance the lethal action of vincristine for micea 
Strain 
Mcvb 
MCVb 
19303� 
19303 
pwb 
rwb 
V5 
V5 b T4bb T4b 
FH-1 
FH-1 
D-9 
D-9 
V-6 
V-6 
T3bb 
T3bb 
H-3 
H-3 
lmg/kg LPS 
lmg/kg LPS 
A420 
43 
43 
40 
40 
36 
36 
42 
42 
39 
39 
40 
40 
46 
46 
43 
43 
39 
39 
41 
41 
lmg VNC/kg 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
No. mice 
10 
10 
10 
20 
10 
20 
10 
10 
10 
10 
10 
10 
10 
20 
10 
20 
10 
20 
10 
10 
30 
10 
10 
% Dead 
0 
0 
0 
15 
0 
45c 
0 
0 
10 
20 
0 
0 
0 
15 
0 
30 
10 
5 
0 
20 
10 
0 
20 
aDUB/ICR male mice were injected simultaneously ip with Listeria 
(0.01 mg/g mouse; the turbidity of the suspension is indicated in 
the table) and lmg VNC/kg when indicated. The percent of animals 
dead within 7 days is recorded. 
bvirulent strains 
cSignificant at p<O.Ol for the VNC-treated mice in contrast to the 
untreated control. 
Combining the results for all strains of�· monocytogenes, the VNC­
treated mice are significantly more sensitive to LPS than the 
untreated mice at p<0.01. 
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TABLE 9 
Capability of heat-killed strains 
of Listeria monocytogenes to produce increased resistance 
to letha1 aoses of bacterial endotoxina 
Strain A420 No. mice % Dead 
MCV 43 8 38 
19303 40 18 22 
PW 36 18 5 
V5 42 8 38 
T4b 39 16 13 
FH-1 40 8 25 
D-9 46 18 11 
V-6 43 18 44 
T3b 39 7 0 
H-3 41 19 11 
none 10 60 
aDUB/ICR male mice were given a single injection of Listeria (0.01 
ml/g mouse; the turbidity of the suspension is indicated in the 
table). About 1 week later, mice were challenged with 20mg E. 
coli 026:86. 
bsignificant at p<0.05 for the VNC-treated mice in contrast to the 
untreated control. 
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Figure 1. Time of death of mice after simultaneous administration of 
bacterial suspension and 1 mg VNC/kg or 20 mg £. coli 026:86 
LPS/kg alone. The number of animals for this experimental 
series was: 10 for 20 mg LPS/kg; 10 for Pseudomonas + 1 mg 
YNC(kg; 20 for Bacteroides+ 1 mg VNC/kg; 20 for Listeria+ 
1 mg VNC(kg. 
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The course of infection of Naegleria fowleri seems to be dose 
dependent whether administered via the intraperitoneal (ip) or intra­
venous (iv) route. Figure 2 shows after iv administration of 1 X 107 
trophozoites/mouse 100% of the mice were dead by day 10 as compared 
to 70% mortality on day 10 for a dose of 5.0 X 106 Naegleria/mouse 
and 40% mortality on day 10 for a dose of 2.5 X 106 trophozoites/ 
mouse. All of the mice in the group receiving 5.0 X 106 trophozoites/ 
mouse were dead by day 13. 
Signs of distress such as ruffled fur and weight loss were not 
observed in mice infected iv with Naegleria. However, one or two days 
prior to death they displayed posterior paralysis with no effect on the 
anterior appendages. When total paralysis was seen in mice prior to 
death they would respond violently to stimuli by a "cork screwing" 
motion. Weight loss and dehydration were seen during this time. 
Occasionally acute deaths occurred within an hour or two of Naegleria 
administration. No signs of CNS involvement were seen with the acute 
deaths. 
Figure 3 shows that mice administered 5.0 X 106 and 1.0 X 107 tropho-
zoites by the ip route had 10% mortality by day 18 and no mortality 
by day 18 respectively. However, all the mice receiving 4.85 X 107 
Naegleria fowleri ip were dead by day 8. Acute deaths were observed 
in mice inoculated with 4.85 X 107 trophozoites/mouse with no signs of 
central nervous system (CNS) involvement. On day 6, however, CNS invol­
vement became apparent as is seen in mice challenged with Naegleria 
fowleri iv. Mice administered 5.0 X 106 Naegleria subcutaneously did 
not die or show signs of CNS involvement. 
Endotoxin and complexes (using portions of the endotoxin mole­
cule complexed to protein carriers) were surveyed to determine whether 
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some protection could be induced in mice infected with Naegleria fowleri. 
Figure 4 shows the results of the effect of endotoxin at a dose of 1 mg/kg 
24 hr prior to injection of Naegleria. Some protection was afforded 
early in the infection with mice pretreated with endotoxin. Towards day 
8 there is no significant difference in survival. 
None of the other agents tested produced substantial protection 
to Naegleria infection in mice. Figure 5, 6, and 7 show survival with 
time of mice pretreated with lipid A complexes and the respective carr­
iers. No significant protection was afforded. 
Figure 8, 9, and 10 show survival with time of mice pretreated with 
dimethylmyristamide-bovine serum albumin, dimethymyristamide, beta­
hydroxy-myristic acid-con A, beta-hydroxy-myristic acid, myristic-BSA, 
and myristic acid, and challenged with Naegleria. None of the above 
agents provided significant protection against the naeglerial infection. 
Figure 11 shows the results of mice pretreated with lipid A and 
challenged with Naegleria iv. Acute deaths were seen in the mice receiv-
1ng Naegleria alone. Those mice receiving lipid A seem to be protected 
from the early deaths seen in the mice receiving Naegleria alone. No sig­
nificant protection is seen later in the course of infection. 
Mice surviving a primary iv injection of Naegleria from previous 
experiments were held for a period of 14 days with no death. The groups 
of mice containing two or more survivors were divided equally and one 
half of the group was rechallenged with 5 X 106 Naegleria/mouse. Figure 
12 shows that the control mice receiving a primary injection of Naegleria 
died within a period of 5-14 days as expected. The mice surviving a 
primary injection with Naelgeria were significantly protected from the 
second challenge. Only one out of seven mice administered a primary 
dose and then rechallenged with Naegleria died. All of the survivors 
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that had received a primary dose of Naegleria but were not rechallen­
ged with Naegleria survived but one. 
Ten of the 18 mice surviving the primary challenge ip with Naegleria 
were rechallenged with Naegleria (5 X 106 trophozoites/mouse iv) 20 
days after primary inoculation (Figure 13). Eight of the survivors 
were held as uninoculated controls. No deaths occurred in the 8 mice that 
received a primary ip injection of Naegleria. Control mice receiving a 
primary injection of Naegleria iv died between the 7th and 14th day. Only 
one out of the 10 mice receiving a primary ip injection and then rechal­
lenged iv with Naegleria died on day 11 post iv inoculation. Signifi­
cant protection was afforded mice pretreated ip with Naegleria and then 
rechallenged iv (Figure 13). 
In a separate experiment ten mice surviving a previous challenge of 
Naegleria iv were divided into two groups. Six were treated with cyclo­
phosphamide and 4 were used as controls. None of the mice treated with 
cyclophosphamide died. One out of the 4 control mice was found dead 
probably killed by another mouse because constant fighting was observed 
and the dead mouse had a large open lesion on his back. 
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Figure 2. Time of death of mice administered varied doses of Naegleria 
fowleri (Lee strain) intravenously (iv). The number of animals 
in each experimental series was 10. 
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Figure 3. Time of death of mice administered varied doses of Naegleria 
fowleri (Lee strain) intraperitoneally (ip). Naegleria 
(5 X 106/mouse) was administered intravenously as a control. 
The number of animals in this experimental series was: 14 
for a dose of 4. 85 X 107 Naegleria ip; 10 for a dose of 5 X 106 
Naegleria iv; 10 for a dose of 5 X 106 Naegleria ip; 8 for a 
dose of 1 X 107 Naegleria ip. 
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Figure 4. The effect of endotoxin on the course of Naegleria infection 
in mice. Mice received 1 mg f. coli 026:B6 LPS/kg ip 24 hr 
prior to iv challenge with Naegleria fowleri (Lee strain). 
Naegleria (5 X 106/mouse) was administered iv as a control. 
The number of animals in this experimental series was: 39 
for no LPS; 40 for lmg LPS/kg. 
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Figure 5. The effect of lipid A-BSA (·····B··�··) or BSA t--� _., on 
the course of Naegleria infection in mice. Mice received 50 mg 
lipid A-BSA/kg or 50 mg BSA/kg ip 24 hr prior to iv challenge 
with Naegleria fowleri (Lee strain). Naegleria (5 X 106/mouse) 
(-e·-� was administered iv as a control. The number of an­
imals in this experimental series was: 27 for lipid A-BSA; 31 
for BSA; 30 for control. 
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Figure 6. The effect of lipid A-Con A on the course of Naegleria infection 
in mice. Mice received 50 mg lipid A-Con A/kg ip 24 hr prior 
to iv challenge with Naegleria fowleri (Lee strain). Naegleria 
(5 X 106/mouse) was administered iv as a control. The number of 
animals for each experimental series was 20. 
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Figure 7. The effect of concanavalin A on the course of Naegleria 
infection in mice. Mice received 50 mg concanavalin A/kg ��@·-) 
ip 24 hr prior to iv challenge with Naegleria fowleri (Lee 
strain). Naegleria (5 X 106/mouse) �-&-) was administered 
iv as a control. The number of animals for this experimental 
series was: 20 for concanavalin A; 19 for control. 
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Figure 8. The effect of N, N dimethylrnyristamide E····&·�·') or N, N 
dimethylmyristamide-BSA (-�-0-----) on the course of Naegleria 
infection in mice. Mice received 50 mg N, N dimethylmyrist­
amide/kg or 50 mg N,N dimethylrnyristamide-BSA/kg ip 24 hr 
prior to iv challenge with Naegleria fowleri (Lee strain). 
Naegleria (5 X 106/mouse) (-e-·) was administered iv as a 
control. The number of animals for each experimental series 
was 20. 
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Figure 9. The effect of beta hydroxymyristic acid (··�·0·····) or beta 
hydroxymyri sti c-Con A (·····•···--) on the course of Naegl eri a 
infection in mice. Mice received 50 mg beta hydroxymyristic 
acid/kg or 50 mg beta hydroxymyristic-Con A/kg ip 24 hr prior 
to iv challenge with Naegleria fowleri (Lee strain). Naegleria 
(5 X 106/mouse) t-�-H-� was administered iv as a control. 
The number of animals for this experimental series was: 30 for 
beta hydroxymyristic-Con A; 29 for control; 17 for beta hydroxy­
myristic acid; 20 for control. 
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Figure 10. The effect of myristic acid (·····•·····) or myristic-BSA �--B--�) 
on the course of Naegleria infection in mice. Mice received 
50 mg myristic acid/kg or 50 mg myristic-BSA/kg ip 24 hr prior 
to iy challenge with Naegleria (5 X 106/mouse) ��(� 
administered iv as a control. The number of animals for each 
experimental series was 20. 
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Figure 11. The effect of lipid A��-·�·�) on the course of Naegleria 
infection in mice. Mice received 50 mg lipid A/kg ip 24 hr 
prior to iv challenge with Naegleria fowleri (Lee strain). 
Naegleria (5 X 106/mouse) �-()--) was administered iv as a 
control. The number of animals for each experimental series 
was 30. 
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Figure 12. Mice receiving a primary iv inoculation with 5 X 106 
Naegleria fowleri (Lee strain)/ mou·se were rechallenged after 
two weeks with 5 X 106 Naegleria/mouse iv. The number of an­
imals for this experimental series was: 7 for iv rechallenged; 
20 for control. 
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Figure 13. Mice administered Naegleria fowleri (Lee strain) ip were 
rechallenged after two weeks with 5 X 106 Naegleria/mouse 
iv. The number of animals for each experimenta�. series was 
10. 
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Discussion 
Previous work has established that many antitumor drugs, given 
in combination with bacterial endotoxin, result in much greater mor­
tality than would be expected. One of these antitumor drugs that 
acts synergistically with bacterial endotoxin is the plant alkaloid 
vincristine (Rose, 1973). A nonlethal dose of vincristine (lmg/kg) 
given in combination with a non-lethal dose of LPS (lmg/kg) results 
in the death of 20% of the treated mice (Table 3). 
The literature has clearly shown that endotoxin in combination 
with vincristine produces one of the most potent enhancements of drug 
lethality known (Rose, 1973). This fact makes the vincristine treated 
mouse an excellent candidate for an assay system to detect small amounts 
of endotoxin. 
It is not unexpected to find that all of the strains of Pseudomonas 
aeruginosa possessed endotoxic activity by the two assay systems used. 
It is well documented in the literature that P. aeruginosa contains 
endotoxin (Sadoff, 1974). 
Bacteroides, being a gram-negative organism, would also be expected 
to show endotoxic activity in the vincristine-treated mouse as well as 
by eliciting protection to the lethal action of LPS. Four of the 
seven strains of Bacteroides showed endotoxic activity in the vincris­
tine-treated mouse and all the strains protected mice against subse­
quent challenge with a lethal dose of LPS. Sonnenwirth et al. (1972) 
have shown that endotoxin is present in LPS extracts from strains of 
�· fragilis and�· melaninogenicus by the Limulus assay. LPS prepara­
tions from B. fragilis and B. melaninogenicus contained ketodeoxyoctonate 
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which is a common constituent of bacterial endotoxin (Sonnenwirth et al ., 
1972). 
Since Bacteroides constitutes a large portion of the normal flora 
of man (Moore and Holdeman, 1974) and bacteremia due to Bacteroides 
has increased over the last 10 years (Sonnenwirth et al ., 1972) the role 
of endotoxin in anaerobic gram-negative bacteremia needs to be clari­
fied. 
Listeria monocytogenes differs from the above organisms in that 
it is a gram-positive organism. An extract from the cell wall of 
Listeria has been isolated and reported to have many of the biological 
activities of endotoxin (Potacka et al .,1974, John et al ., 1974, 
and Srivastava and Siddique, 1975). Endotoxic activity was found in 
both assays for heat-killed Listeria strains 19303, PW, 09, and H-3. 
No endotoxic activity was found for strains MCV, V-5, T4b and FH-1. 
Cells of strain T3b produced increased resistance to LPS but did not 
kill vincristine-treated mice. 
MCV, 19303, PW, T4b and T3b strains were human isolants and patho­
genic for mice whereas H-3, V-5, V-6, FH-1 and 0-9 strains were iso­
lated from vegetation and considered avirulent. Endotoxin-like activity 
did not seem to be contingent on whether the organism was virulent or 
avirulent. 
The lack of endotoxic activity of some of the strains of Bacteroides 
and Listeria in the vincristine treated mouse may be due to the use of 
whole bacteria in which the endotoxin might not have been released be­
fore the vincristine had been excreted. Alternatively LPS might have 
been released into the growth medium in the case of Bacteroides and 
Listeria or washing fluids in the case of Listeria. 
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All three of the above organisms are easily isolated from man or 
the environment and are not usually pathogenic except in the compromised 
host. The clinician should be aware that synergies with antineoplastic 
agents (such as VNC) and endotoxin-like substances from opportunistic 
organisms could cause death in patients concurrently receiving cyto­
toxic drugs such as antineoplastic agents and immunosuppressants. 
Previous work has established that bacterial endotoxins may enhance 
or inhibit the pathogenicity of infection depending on the infecting 
microorganism, dose and route of injection of endotoxin, and the inter­
val between administration of toxin and initiation of infection. Ef­
fects of endotoxin on resistance have been demonstrated in infection by 
protozoa (Trypanosoma, Plasmodium), fungi (Candida, Rhizopus, Blasto­
myces, Histoplasma, Cryptococcus), viruses (influenza, ectromelia, 
encephalitis, and New Castle disease), gram-positive bacteria (Staphy­
lococcus, Pneumococcus, Streptococcus), gram-negative bacteria 
(Klebsiella, Pseudomonas, Salmonella, Escherichia coli), and Myco­
bacterium (Cluff, 1971). The mechanism for this alteration of infection 
is not known. Endotoxin affects the cellular and humoral mechanisms 
that control resistance. Also the action of endotoxin may be altered 
by an animal's nutritional state, metabolic state, age, sex, and other 
constitutional characteristics. 
Naegleria fowleri infection was used to determine if endotoxin 
and endotoxin-like material could alter the course of infection. The 
mouse was chosen as the experimental animal because the existence of 
primary amebic meningoencephalitis in man was suggested following the 
discovery of fatal meningoencephalitis in mice after intranasal ino­
culation of a species of Acanthameba. When primary amebic meningoence­
phalitis was subsequently reported in humans, the remarkable similarity 
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of the disease occurring in man to that produced experimentally was 
promptly recognized (Culbertson et al., 1958). Also, the basic features 
of the disease in man have all been noted in experimental infections in 
the mouse namely the same incubation period and portal of entry and 
central nervous system involvement (Martinez et al ., 1973). 
The intranasal route of inoculation has been the classical way of 
tnoculating mice or most experimental animals with Naegleria since it 
has been thought to be the route of entry in primary amebic meningo­
encephalitis in man. Small numbers of Naegleria administered by the 
intranasal route are able to produce primary amebic meningoencephalitis 
in experimental animals. However, with intranasal inoculation it is 
extremely difficult to quantitate the number of trophozoites given. 
Mice were inoculated by the subcutaneous, intraperitoneal, and 
intravenous routes. Clinical symptoms and death were produced in mice 
inoculated via the intravenous and intraperitoneal route. Only one 
dose l5 X 106 trophozoites/mouse) was administered subcutaneously. 
Since the course of infection of the Naegleria infection seems to be 
dose dependent via the iv and ip route it is reasonable to propose 
that a larger dose can produce the disease in mice via subcutaneous 
inoculation. 
Intravenous inoculation was chosen over other routes of inoculation 
for subsequent experiments because it produced clinical symptoms and 
death in mice in a reasonable amount of time (5-7 days) and required a 
reasonable number of trophozoites (5 X 106 trophozoites/mouse). 
Culbertson et al. (1968) reported inoculation of mice with Naegleria 
via the intranasal as well as the intraperitoneal, intravenous and 
intracerebral routes. According to Culbertson et al. if 100-10000 
Naegleria were instilled intranasally, mice died in 8-10 days of "rhinen-
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cephalitis". They also stated that wide hematogenous dissemination was 
seen after intravenous and intraperitoneal administration (Culbertson et 
al.' 1968). No tables, figures or doses for Naegleria administered iv or 
ip are available. 
In 1972 Culbertson et al. reported inoculating Naegleria into 
subcutaneous and skeletal muscle tissue of guinea pigs and specific 
pathogen free mice. Doses of 8 X 104 to 1 X 105 amebae were admin­
istered im or subcutaneously. It was determined that most guinea 
pigs died without central nervous system involvement after receiving 
1 X 104 amebae. It was stated that comparable experiments were repeated 
in SPF mice and that mice were not as susceptible as guinea pigs to 
infection by Naegleria after subcutaneous injection. Again no dose of 
Naegleria was reported (Culbertson et al ., 1972). 
Carter (1970) studied the pathogenicity of the Naegleria by various 
routes of inoculation. Swiss Webster mice were inoculated in groups of 
3 by the intranasal, intragastric, intrarectal, intravenous, intramus-
cular, subcutaneous, intraperitoneal, intrahepatic, intrapleural, anterior 
intracerebral, and posterior intracerebral routes. A dose of 2 X 104 
Naegleria in proteose peptone glucose medium with a pH of 6.5 and a 
molarity of 0.135 M was administered each mouse. Clinical symptoms 
and death occurred only in mice administered Naegleria intranasally, 
anterior intracerebrally, and posterior intracerebrally. One out of 
three mice died with no clinical symptoms in both of the groups admin­
istered Naegleria intravenously and intrahepatically. No clinical or 
pathological evidence of disease was found when Naegleria were admin­
istered via the intrarectal, intragastric, intramuscular, intraperitoneal, 
subcutaneous, or intrapleural routes (Carter, 1970). 
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Wong (1975) inoculated Naegleria via the intranasal, intrathecal, 
and intravenous routes into monkeys. Wong administered 1 X 104 to 4 X 105 
Naegleria/monkey intranasally, 2.8 X 104 to 3 X 105 Naegleria/monkey intra­
venously and 2.5 X 104 to 1 X 106 Naegleria/monkey intrathecally. No clin­
ical symptoms or death resulted in monkeys inoculated intranasally or 
1ntravenously using the doses of Naegleria described above. Clinical symp­
toms occurred in all monkeys and death in some monkeys inoculated intra­
thecally (Wong, 1975). 
The literature on route of inoculation of Naegleria is not convinc­
ing because too few animals composed the experimental groups, the numbers 
of trophozoites administered were not reported or too small a dose of 
amebae was administered, and the ages of the Naegleria cultures were not 
stated. 
Mice pretreated with bacterial LPS 24 hr prior to iv challenge with 
Naegleria were afforded protection early in the course of infection. This 
early protection from naeglerial infection may have been due to a response 
of the host to LPS which caused products to be formed or cells to be 
mobilized in the host that were deleterious to the Naegleria. Since the 
ability of Naegleria to establish a progressive disease is dose dependent, 
survival times of the mice would be increased if the numbers of Naegleria 
were decreased by the host response. 
Mice pretreated with LPS were definitely protected from the acute 
deaths that were occasionally observed in mice inoculated iv with Naegleria 
alone. These acute deaths may have been caused by the toxin that is 
reportedly produced by Naegleria (Chang, 1971). 
None of the other endotoxin-like substances tested afforded protec­
tton from Naegleria infection in mice except possibly lipid A. According 
to Luderitz et al. (1973), lipid A is the active toxic component of LPS. 
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They reported that lipid A complexed with certain carriers was less active 
than its parent LPS but did show endotoxic activity in the following assays: 
mouse lethality, pyrogenicity, bone marrow necrosis, Limulus gelation and 
complement inactivation (Luderitz et al ., 1973). Thus it was disappoint­
ing that the lipid A complexes showed no alteration of the course of the 
naeglerial infection. Lipid A alone prolonged survival time of mice 
early in the infection. By day 6 post injection there was no significant 
protection. Significant protection was afforded mice from acute deaths 
observed in mice administered Naegleria alone. 
Mice that survived a primary dose of Naegleria iv or ip were sig­
nificantly protected from a rechallenge with Naegleria iv. This effect 
can probably be attributed to increased immunity of the host to naeglerial 
infection. The initial challenge of Naegleria acted as a vaccine. 
The possibility that a latent infection might become manifest and 
produce disease in a compromised host prompted the experiment using 
cyclophosphamide on survivors. The experiment did not have any controls 
to show that the dose of cyclophosphamide used immunosuppressed the 
animals. 
The study presented here introduces many questions that need to 
be pursued. Some stem from subjective observations made during the 
research. One observation is that Naegleria seem to become more vir­
ulent after frequent transfer of the cultures in culture media. Naegleria 
can be transferred with varying time intervals between transfers and 
dose response in mice results calculated. Along this same vein, non­
pathogenic Naegleria might be rapidly transferred in culture media and 
administered to mice to see whether death could be produced. 
The question of the cause of acute deaths in mice administered 
Naegleria iv and ip needs to be resolved. Is it a toxin? One way to 
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determine whether Naegleria must be present for acute deaths to occur 
would be to inoculate mice with the supernatant fluid from the Naegleria 
suspension that has been prepared in the normal manner for iv inoculation. 
Since it has been shown previously that time of administration of 
LPS influences the degree of protection (MacGregor et al ., 1969), many 
doses of LPS should be used to pretreat mice and varying time of adminis­
tration of LPS should be tried. 
Tolerance or increased resistance to the deleterious effects of 
bacterial endotoxins ensues after exposure of experimental animals to a 
single or multiple injections of such toxins (Moreau and Skarnes, 1973). 
MacGregor et al. (1969) failed to show protection from malaria infection 
in LPS tolerant mice. Singer et al. (1964) have shown that animals 
tolerant to LPS were protected from trypanosome infection. Because of 
varying reports, it would be interesting to see if the course of naeglerial 
infection could be altered in the LPS tolerant mouse. 
The question of the course of infection of Naegleria in the immuno­
suppressed mouse is still unanswered. Experiments should be done to 
determine a dose of drug that would immunosuppress the animal. Then the 
dose could be used on survivors to see if one could produce the disease 
in a compromised host. The immunosuppressive drug could also be used to 
see if a compromised host was more susceptible to the infection than a 
"normal" animal. 
A survey of drugs would be advantageous to determine if Naegleria 
infection could be inhibited or cured. One should initiate this study 
with drugs that are able to cross the blood brain barrier. Time of ad­
ministration of drugs would probably also be important. 
Protection of animals from a secondary challenge using doses of live 
Naegleria iv and ip has already been shown. Protection of mice from 
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naeglerial infection might be afforded by using frozen or heat killed 
cells as a vaccine. One might also administer live trophozoites in 
multiple low doses and challenge with a large dose of Naegleria to see 
if animals are protected. Doses of nonpathogenic Naegleria might also 
be used as a vaccine. 
Many interesting experiments are left to be done with naeglerial 
infection in mice. These experiments may answer many of the questions 
that make this organism such a mystery. Can a common soil ameba Naegleria 
become a pathogen? If so, is it the environment or the host or both? 
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SUMMARY 
In this study the distribution and effects of bacterial endotoxin 
were examined. Adult male BALB/c and adult male DUB/ICR mice were used 
in all experiments. Endotoxic activity of a number of strains from 
three genera of bacteria, Pseudomonas, Bacteroides, and Listeria, was 
detected using vincristine-treated mice as sensitized indicators for 
endotoxin and resistance to purified endotoxin induced by pretreatment 
with selected bacteria. Also, the effect of bacterial endotoxin and 
endotoxin-like substances on the course of primary amebic meningoen­
cephalitis in mice, caused by Naegleria fowleri, was assessed. 
Cells from 10 mucoid strains of Pseudomonas aeruginosa, isolated 
from patients with cystic fibrosis, were harvested, suspended in saline 
and killed by heating in a boiling water bath for 10 min. Mice were 
administered a cell-suspension having an absorbance at 420 nm of about 
10(0.01 ml/gram of mouse) simultaneously with 1 mg vincristine /kg. 
All 10 strains of Pseudomonas possessed endotoxic activity. Moreover 
treatment of mice with heat-killed Pseudomonas rendered the animals 
resistant to a dose of lipopolysaccharide (LPS) that killed untreated 
mice. Cells from 7 strains of Bacteroides were harvested, suspended in 
saline and frozen. Mice were administered a cell-suspension having an 
absorbance at 420 nm of about 40(0.01 ml/gram mouse). Four of the 
Bacteroides strains possessed endotoxic activity by this assay. All 7 
strains were able to evoke resistance to a lethal dose of LPS. Cells 
from 10 strains of Listeria monocytogenes were examined; about half of 
these possessed endotoxin-like activity by both assay systems used. 
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The course of the disease after infection of mice with Naegleria 
fowleri was dose dependent, whether challenged via the intraperitoneal 
(ip) or intravenous (iv) route. After iv administration of 1 X 107 
trophozoites/mouse 100% of the mice were dead by day 10 as compared to 
70% mortality on day 10 for a dose of 5 X 106 Naegleria/mouse and 40% 
mortality on day 10 for a dose of 2.5 X 106 trophozoites/mouse. Mice 
administered 5 X 106 and l X 107 trophozoites by the ip route had 10% 
and no mortality by day 18 respectively. However, all the mice re­
ceiving 4.85 X 107 Naegleria ip were dead by day 8. Mice were pretreated 
with LPS (lmg/kg) and endotoxin-like materials (50mg/kg) 24 prior to iv 
challenge with Naegleria fowleri (5 X 106 trophozoites/mouse). Mice 
pretreated with Escherichia coli 026:B6 LPS before challenge, displayed an 
increase in resistance during the early portion of the naeglerial disease. 
Mice pretreated with endotoxin-like materials such as lipid A complexed 
to bovine serum albumin (BSA), lipid A complexed to concavalin A (Con A), 
bovine serum albumin, concanavalin A, beta hydroxymyristic acid, beta 
hydroxymyristic-Con A, myristic acid, myristic-BSA, N,N dimethylmyristic­
BSA and N,N dimethylmyristic acid were afforded no protection from the 
naeglerial infection. 
Mice that survived a primary iv or ip challenge with Naegleria 
fowleri were rechallenged iv with 5 X 106 Naegleria/mouse. These mice 
were significantly protected from the second challenge with Naegleria 
fowleri. The initial challenge with Naegleria acted as a vaccine . 
• 
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